Fig. 7
From: Consequences of blunting the mevalonate pathway in cancer identified by a pluri-omics approach
PCA analysis of the kinetic effects of the (lovastatin + docetaxel) combination. The cells were treated with both drugs for the indicated times (H) and cell extracts were prepared for GC-MS analysis. Seventeen-hours control (open squares), 24 h control (gray squares), 36 h control (black squares), 17 h treament (empty circles), 24 h treatment (gray circles), and 36 h treatment (black circles). Three biological replicates of each treatment condition were performed
